Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CATO compared with MGX: revenue, margins and what each company keeps, and the suppliers and customers both name
CATO
Cato Corp
Change
Mkt cap
Revenue
Revenue
MGX
Metagenomi Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CATO
Cato Corp
vs
MGX
Metagenomi Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
CATO
Cato Corp
Change
2.37
▲
+1.72%
Mkt cap
$46.4M
Revenue
$166M
Q2 FY26
Revenue
$654M
FY25
MGX
Metagenomi Therapeutics, Inc.
Change
0.76
▲
+0.79%
Regular session
Nov 4 '26
Mkt cap
$28.7M
Revenue
$1M
Q1 FY26
Revenue
$25M
FY25
vs
Compare
Regular session
Nov 4 '26
CATO
Cato Corp
vs
MGX
Metagenomi Therapeutics, Inc.
2.37
▲
+1.72%
Price
0.76
▲
+0.79%
$46.4M
Mkt cap
$28.7M
Q2 FY26
$166M
Revenue
$1M
Q1 FY26
FY25
$654M
Revenue
$25M
FY25
Change
Change
CATO
2.37
▲
+1.72%
vs
MGX
0.76
▲
+0.79%
Regular session
Nov 4 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
MGX: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CATO
0
None
Shared
0
No disclosed counterparties: CATO.
Only MGX
2
IONS
Ionis Pharmaceuticals
customer
—
Acuitas Therapeutics
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CATO, solid
MGX, dashed